HENDRIX BLAIR E
Transaction: 06/18/2026
BUY
Change
+34,364
Price
$14.55
Filing
07/14/2026
Type
BUY
Surgery Partners, Inc.
SGRY • Medical - Care Facilities
$14.26
▲ +0.09 (+0.64%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$1.84B
Growth
12.8%
Cash Flow
5/5
Trend
Stable
Evidence
Positive free cash flow · 1.54Consistent free cash flow · 5/5Healthy liquidity · 1.87High debt level · 2.35Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 12, 2026, 12:11 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$14.26
Change0.64%
Shares Out128.82M
Market Cap$1.84B
Enterprise Value$1.99B
52W Range11.41 - 24.10
Beta1.94
P/E-20.73
P/S0.55
P/B1.10
P/FCF9.79
EV/Sales0.59
Price$14.26
Change0.64%
Shares Out128.82M
Market Cap$1.84B
Enterprise Value$1.99B
52W Range11.41 - 24.10
Beta1.94
P/E-20.73
P/S0.55
P/B1.10
P/FCF9.79
EV/Sales0.59
EV/EBITDA2.07
EV/FCF10.61
Earnings Yield-4.82%
FCF Yield10.21%
Dividend Yield0.00%
Gross Margin23.12%
Oper. Margin11.77%
Profit Margin-2.35%
Debt/Eq2.35
Current Ratio1.87
Quick Ratio1.71
Revenue 5Y12.85%
FCF 5Y4.52%
Target$18.75
Target Upside31.49%
Target Median$18.50
Target Range17.00 - 21.00
Volume1.64M
Avg Volume1.43M
EPS Surprise0.12
Investment DNA
How strong this company looks for long-term investors
62
out of 100
Business Quality
Margins, moat, returns
33/100
Financial Strength
Debt, cash, stability
56/100
Growth Potential
Revenue and expansion
58/100
Price Attractiveness
Cheap or expensive today
91/100
Why this score▼
Positive free cash flow · 1.54Consistent free cash flow · 5/5Healthy liquidity · 1.87High debt level · 2.35Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 22 analyst votes · 2026-09-05
82/100
Bullish
Bullish
14
Hold
8
Bearish
0
Price Target
2026-08-12
Low
$17.00
Mean
$18.75
Median
$18.50
High
$21.00
Insider Transactions
Recent executive and insider activity
TURNER BRENT
Transaction: 06/05/2026
BUY
Change
+11,670
Price
$13.71
Filing
06/09/2026
Type
BUY
DeLuca Teresa
Transaction: 06/05/2026
BUY
Change
+11,670
Price
$13.71
Filing
06/09/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| HENDRIX BLAIR E | BUY | +34,364 | $14.55 | 06/18/2026 | 07/14/2026 |
| TURNER BRENT | BUY | +11,670 | $13.71 | 06/05/2026 | 06/09/2026 |
| DeLuca Teresa | BUY | +11,670 | $13.71 | 06/05/2026 | 06/09/2026 |
| Dean Lloyd H | BUY | +11,670 | $13.71 | 06/05/2026 | 06/09/2026 |
| ADLERZ CLIFFORD G | BUY | +11,670 | $13.71 | 06/05/2026 | 06/09/2026 |
| Forese Laura L | BUY | +11,670 | $13.71 | 06/05/2026 | 06/09/2026 |
| Deane John A | BUY | +11,670 | $13.71 | 06/05/2026 | 06/09/2026 |
| HENDRIX BLAIR E | BUY | +11,670 | $13.71 | 06/05/2026 | 06/09/2026 |
| Evans Jason Eric | SELL | -20,400 | $12.47 | 03/16/2026 | 03/16/2026 |
| Doherty David T | SELL | -8,867 | $12.50 | 03/16/2026 | 03/16/2026 |
| Brittenham Marissa | SELL | -3,657 | $12.54 | 03/13/2026 | 03/16/2026 |
| Burkhalter Danielle | SELL | -3,469 | $12.83 | 03/13/2026 | 03/16/2026 |
| Baldock Jennifer | SELL | -5,798 | $13.17 | 03/12/2026 | 03/16/2026 |
| Brittenham Marissa | SELL | -8,785 | $13.70 | 03/06/2026 | 03/09/2026 |
| Webb William Trenton | SELL | -272 | $13.93 | 03/06/2026 | 03/09/2026 |
| Burkhalter Danielle | SELL | -7,736 | $13.60 | 03/06/2026 | 03/09/2026 |
| Baldock Jennifer | SELL | -10,082 | $13.70 | 03/06/2026 | 03/09/2026 |
| Doherty David T | SELL | -14,574 | $13.84 | 03/06/2026 | 03/09/2026 |
| Evans Jason Eric | SELL | -11,462 | $13.79 | 03/06/2026 | 03/09/2026 |
| Oppenheimer Justin Robert | BUY | +42,523 | $14.11 | 03/05/2026 | 03/09/2026 |